Product Details
Formula
C16H18F6N5O5P
MW
505.31
Purity
>97%
Solubility (DMSO Mg/MI)
90
Storage (Powder)
3 Years -20°C
Storage (Solvent)
1 Year -80°C
Indication
N/A
Mode Of Action
inhibitor
Drug Status
Approved
Target Name
Dipeptidyl peptidase 4 (DPP-4)
Research Area
METABOLIC
Research Area Sub Group
Hypoglycemic
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Protease
Bio Chemical Notes
Sitagliptin acts as a dipeptidyl peptidase-4 (DPP-4) inhibitor, used to improve glycemic control in patients with type II diabetes. Ref: Clinical Therapeutics 2006; 28 (10); 1556-1568.